These results indicate that the IL-10–STAT3 pathway in macrophages could be a good target for the development of effective therapies to block macrophage-promoted cyst expansion and accordingly slow ADPKD disease progression. Here, STAT3 is linked to autosomal dominant polycystic kidney disease.